Suppliers / Sunny Pharmtech

Sunny Pharmtech

Taiwan Updated 9 July 2026

Sunny Pharmtech is an API manufacturer based in Taiwan. It holds 3 active US drug master files across a filed portfolio of 3 molecules. Its most recent recorded inspection, by US FDA, closed on 15 April 2022 as VAI.

3
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 15 April 2022 VAI US FDA
  • 18 October 2019 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Taiwan, Taiwan 3013166187

What they file, and where

Molecule Regulators Docs
Aminocaproic Acid US FDA 1
Cyclophosphamide US FDA 1
Phylloquinone US FDA 1

Also appears on these molecule pages

Aminocaproic Acid API Cyclophosphamide API Phylloquinone API

Comparing suppliers?

Choose your molecules and target markets. Sunny Pharmtech comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 15 April 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability